NIHA QAMAR

Allopathic & Osteopathic Physicians|Allergy & Immunology FRESH MEADOWS, NY NPI 1447526355

General Payments — all program years on this page

$3,136.07

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 134
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $858.75 across 39 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $858.7539

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $169.084
2019 $254.258
2020 $41.452
2021 $365.7619
2022 $475.9822
2023 $970.8040
2024 $858.7539

Records — PY2024 (39)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1104317800 AstraZeneca Pharmaceuticals LP $20.14 10/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104714431 AstraZeneca Pharmaceuticals LP $22.48 09/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105505850 AstraZeneca Pharmaceuticals LP $22.19 08/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105670463 AstraZeneca Pharmaceuticals LP $20.96 12/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105701784 AstraZeneca Pharmaceuticals LP $21.60 02/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114141319 Regeneron Healthcare Solutions, Inc. $21.76 02/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114141321 Regeneron Healthcare Solutions, Inc. $24.99 03/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114141323 Regeneron Healthcare Solutions, Inc. $22.87 06/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114141325 Regeneron Healthcare Solutions, Inc. $29.11 10/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114141327 Regeneron Healthcare Solutions, Inc. $24.42 11/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114141329 Regeneron Healthcare Solutions, Inc. $24.95 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116032813 Amgen Inc. $23.61 02/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116032820 Amgen Inc. $21.80 03/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116032826 Amgen Inc. $22.39 04/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116183890 GlaxoSmithKline, LLC. $16.87 02/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116235592 GlaxoSmithKline, LLC. $18.65 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116291578 GlaxoSmithKline, LLC. $15.71 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116367441 GlaxoSmithKline, LLC. $19.77 04/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116465542 GlaxoSmithKline, LLC. $18.98 12/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116615106 GlaxoSmithKline, LLC. $16.52 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116632637 GlaxoSmithKline, LLC. $12.81 10/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116661473 GlaxoSmithKline, LLC. $16.87 07/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116663677 GlaxoSmithKline, LLC. $16.87 01/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117480344 BioCryst US Sales Co., LLC $20.51 05/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1126628674 kaleo, Inc. $22.87 05/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1126628676 kaleo, Inc. $26.54 04/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1126628678 kaleo, Inc. $25.40 07/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1126628680 kaleo, Inc. $24.99 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1127507979 Hikma Pharmaceuticals USA $19.23 05/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1127508005 Hikma Pharmaceuticals USA $21.07 08/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139860668 GENZYME CORPORATION $30.73 02/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139860686 GENZYME CORPORATION $36.91 06/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139860694 GENZYME CORPORATION $29.73 07/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139860712 GENZYME CORPORATION $35.23 09/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139860714 GENZYME CORPORATION $3.18 10/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139860722 GENZYME CORPORATION $12.58 11/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139860726 GENZYME CORPORATION $25.14 11/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1142177818 Optinose US, Inc. $27.94 05/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1142177894 Optinose US, Inc. $20.38 12/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.